E-LIB Suche - Ergebnisse für: Uyl-de Groot, Carin A

1

The Role of Medical Societies and the Relevance of Clinical..:

Julian, Elaine ; Solà-Morales, Oriol ; Garcia, Maria João...
Journal of Market Access & Health Policy. 12 (2024) 3 - p. 128-143 , 2024

Link: https://doi.org/10.3390/..

2

A health technology assessment of personalized nutrition in..:

Galekop, Milanne Maria Johanna ; del Bas, Josep Maria ; Calder, Philip C...
International Journal of Technology Assessment in Health Care. 40 (2024) 1 - p. , 2024

Link: https://doi.org/10.1017/..

3

Preferences and willingness to pay for personalized nutriti..:

Galekop, M.M.J. ; Veldwijk, J. ; Uyl-de Groot, C.A..
Food Quality and Preference. 113 (2024) - p. 105075 , 2024

Link: https://doi.org/10.1016/..

4

Challenges and controversies in resectable non-small cell l..:

Houda, Ilias ; Dickhoff, Chris ; Uyl-de Groot, Carin A....
The Lancet Regional Health - Europe. 38 (2024) - p. 100841 , 2024

Link: https://doi.org/10.1016/..

5

New systemic treatment paradigms in resectable non-small ce..:

Houda, Ilias ; Dickhoff, Chris ; Uyl-de Groot, Carin A....
The Lancet Regional Health - Europe. 38 (2024) - p. 100840 , 2024

Link: https://doi.org/10.1016/..

6

Disease-Free Survival of Patients With Muscle-Invasive Blad..:

Brück, Katharina ; Meijer, Richard P. ; Boormans, Joost L....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 1 - p. 41-49 , 2024

Link: https://doi.org/10.1016/..

7

Applying a cost-based pricing model for innovative cancer t..:

Heine, R. J. S. D. ; Thielen, F. W. ; Mathijssen, R. H. J....
PLOS ONE. 19 (2024) 2 - p. e0293264 , 2024

Link: https://doi.org/10.1371/..

8

Assessing the clinical benefit of systemic anti-cancer trea..:

Leeneman, Brenda ; Xander, Nicolas S.H. ; Fiets, W. Edward...
European Journal of Cancer. 202 (2024) - p. 114002 , 2024

Link: https://doi.org/10.1016/..

9

Broadening the HTA of medical AI: A review of the literatur..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Visser, Jacob J...
Health Policy and Technology. 13 (2024) 2 - p. 100868 , 2024

Link: https://doi.org/10.1016/..

10

Non-contrast short MRI surveillance for HCC screening: the ..:

van de Braak, Céline ; Willemssen, François E. J. A. ; de Man, Rob A....
European Radiology Experimental. 8 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

11

Attitudes Toward the Adoption of Remote Patient Monitoring ..:

Godoy Junior, Carlos Antonio ; Miele, Francesco ; Mäkitie, Laura...
The Patient - Patient-Centered Outcomes Research. 17 (2024) 3 - p. 275-285 , 2024

Link: https://doi.org/10.1007/..

12

Unraveling elements of value-based pricing from a pharmaceu..:

Dane, Aniek ; Uyl-de Groot, Carin ; van der Kuy, Hugo
Frontiers in Pharmacology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

13

Market entry agreements for innovative pharmaceuticals subj..:

Heine, Renaud J.S.D. ; Mathijssen, Ron H.J. ; Verbeek, Floor A.J...
Value in Health. , 2024

Link: https://doi.org/10.1016/..

14

CO131 Using Non-Randomized Trials to Assess the Clinical Be..:

Xander, N. ; Leeneman, B. ; Dingemans, A.M.C....
Value in Health. 26 (2023) 12 - p. S37-S38 , 2023

Link: https://doi.org/10.1016/..

15

Cost-Effectiveness Analysis of MammaPrint® to Guide the Use..:

Luyendijk, Marianne ; Jager, Agnes ; Buijs, Sanne M....
PharmacoEconomics. 41 (2023) 8 - p. 981-997 , 2023

Link: https://doi.org/10.1007/..